Analysis the level of autoantibodies in diabetic ketoacidosis in pediatric practice

diabetes mellitus, diabetic ketoacidosis, autoantibodies, dopamine receptors, NMDA receptors

1. Chiarelli F, Rewers M, Phillip M. Screening of Islet Autoantibodies for Children in the General Population: a Position Statement endorsed by the European Society for Pediatric Endocrinology. Horm Res Paediatr. 2022. https://doi.org/10.1159/000525824. Online ahead of print.

2. Pasi R, Ravi KS. Type 1 diabetes mellitus in pediatric age group: A rising endemic. J Family Med Prim Care. 2022; 11 (1): 27-31. https://doi.org/10.4103/jfmpc.jfmpc_975_21.

3. Raghunathan V, Jevalikar G, Dhaliwal M, Singh D, Sethi SK, Kaur P, Singhi SC. Risk Factors for Cerebral Edema and Acute Kidney Injury in Children with Diabetic Ketoacidosis. Indian J Crit Care Med. 2021; 25 (12): 1446-1451. https://doi.org/10.5005/jp-journals-10071-24038.

4. Baszynska-Wilk M, Wysocka-Mincewicz M, Wajda-Cuszlag M, Swiercz A, Szalecki M. Letter to the Editor: Central Nervous System Complications in Diabetic Ketoacidosis. Pediatr Endocrinol Rev. 2019; 17 (1): 47-49. https://doi.org/10.17458/per.vol17.2019.le.bwwmwc.nervouscomplicationsdiabetic.

5. Gardoni F, Stanic J, Scheggia D, Benussi A, Borroni B, Di Luca M. NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features. Cells. 2021; 10 (1): 77. https://doi.org/10.3390/cells10010077.

6. Arinuma Y. Antibodies and the brain: anti-N-methyl-D-aspartate receptor antibody and the clinical effects in patients with systemic lupus erythematosus. Curr Opin Neurol. 2018; 31 (3): 294-299. https://doi.org/10.1097/WCO.0000000000000554.

7. Klein MO, Battagello DS, Cardoso AR, Hauser DN, Bittencourt JC, Correa RG. Dopamine: Functions, Signaling, and Association with Neurological Diseases. Cell Mol Neurobiol. 2019; 39 (1): 31-59. https://doi.org/10.1007/s10571-018-0632-3.

8. Dale RC, Merheb V, Pillai S, Wang D, Cantrill L, Murphy TK, Ben-Pazi H, Varadkar S, Aumann TD, Horne MK, Church AJ, Fath T, Brilot F. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain. 2012; 135 (11): 3453-3468. https://doi.org/10.1093/brain/aws256.

9. Bykov YuV, Baturin VA, Uglova TA. Ocenka urovnej autoantitel k NMDA i dofaminovym receptoram u detej bol'nyh saharnym diabetom I tipa v zavisimosti ot tyazhesti techeniya zabolevaniya. Medicina. 2020; 8 (2): 73-80. (In Russ.). https://doi.org/10.29234/2308-9113-2020-8-2-73-80.